Recombinant viruses as vectors for mucosal immunity

Current Topics in Microbiology and Immunology

Volumn 236, Issue , 1999, Pages 255-273

  Morrow, C D ^a   Novak, M J ^a   Ansardi, D C ^a   Porter, D C ^a   Moldoveanu, Z ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT DNA; VIRUS DNA; VIRUS VECTOR;

ALPHA VIRUS; GENE EXPRESSION REGULATION; IMMUNOTHERAPY; NONHUMAN; PICORNAVIRUS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REVIEW; VIRUS TRANSMISSION;

ALPHAVIRUS; DNA VIRUSES; PICORNAVIRIDAE; POLIOVIRUS; RNA VIRUSES;

EID: 0032890397     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-59951-4_13     Document Type: Review

References (12)

1. Almond JW, Burke KL (1990) Poliovirus as a vector for the presentation of foreign antigens. Semin Virol 1:11-20
2. Altmeyer R, Escriou N, Girard M, Palmenberg A, van der Werf S (1994) Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120. Proc Natl Acad Sci USA 91:9775-9779
3. Andino R, Silvera D, Suggett SD, Achacoso PL, Miller CJ, Baltimore D, Feinberg MB (1994) Engineering poliovirus as vaccine vector for the expression of diverse antigens. Science 265:1448-1451
4. Ansardi DC, Moldoveanu Z, Porter DC, Walker DE, Conry RM, LoBuglio AF, McPherson S, Morrow CD (1994) Characterization of poliovirus replicons encoding carcinoembryonic antigens. Cancer Res 54:6359-6363
5. Ansardi DC, Morrow CD (1993) Poliovirus capsid proteins derived from PI precursors with glutamine-valine cleavages sites have defects in assembly and RNA encapsidation. J. Virol., 67:7284-7297
6. Belshe RB, Newman FK, Ray R (1996) Parainfluenza Virus Vaccines. In: H Kiyono, PL Orga, JR McGhee, (eds) Mucosal Vaccines. Academic Press, San Diego, pp 311-319
7. Buge SL, Richardson E, Alipanah S, Markham P, Cheng S, Kalyan N, Miller CJ, Lubeck M, Udem S, Eldridge J, Guroff MR (1997) An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in Rhesus Macaques and decreases viral burden following vaginal challenge. J Virol 71:8531-8541
8. Connor ME, Estes MK, Offit PA, Clark HF, Franco M, Feng Jr. N, Greenberg Jr. H (1996) Development of a mucosal rotavirus vaccine. In: H Kiyono, PL Orga, JR McGhee (eds) Mucosal Vaccines. Academic Press, San Diego, pp 325-339
9. Couch RB, Cate TR, Keitel WA (1996) Oral immunization with influenca virus vaccines. In: H Kiyono, PL Orga, JR McGhee (eds). Mucosal Vaccines. Academic Press, San Diego, pp 303-308
10. Davis AR, Kostek B, Mason BB, Hsiao CL, Morin J, Dheer SK, Hung PP (1985) Expression of hepatitis B surface antigen with a recombinant adenovirus. Proc Natl Acad Sci USA 82:7560-7564
11. Davis ML, Brown KW, Johnston RE (1996) A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J Virol 70:3781-3787
12. Dewar RL, Natarajan V, Vasudevachari MB, Sakzman NP (1989) Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus. J Virol 63:129-136